檢索結果 - Zhaoping Su
- Showing 1 - 3 results of 3
-
1
-
2
-
3
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors 由 Mingchuan Zhao, Xichun Hu, Pengpeng Zhuang, Aiping Zeng, Yan Yu, Zhendong Chen, Hongmei Sun, Weihua Yang, Lili Sheng, Peijian Peng, Jingfen Wang, Tienan Yi, Minghong Bi, Huaqiu Shi, Mingli Ni, Xiumei Dai, Chang-Lu Hu, Hongjie Xu, Dongqing Lv, Qingshan Li, Kaijian Lei, Xia Yuan, Ou Jiang, Xicheng Wang, Baihui Hu, Zhé Hóu, Zhaoping Su, Song Zheng, Ming Zhou, Changlin Dou
出版 2025Artigo
相關主題
Internal medicine
Medicine
Alternative medicine
Atherosclerotic cardiovascular disease
Biosimilar
Bone metastasis
Cancer
Cardiology
Cause of death
Confidence interval
Denosumab
Disease
Double blind
Engineering
Environmental health
Hazard ratio
Insulin
Intensive care medicine
Ischemia
Ischemic stroke
Mechanical engineering
Metastasis
Modified Rankin Scale
Odds ratio
Oncology
Osteoporosis
Pathology
Placebo
Plasma glucose
Population